======= GOT2 ======= == Gene Information == * **Official Symbol**: GOT2 * **Official Name**: glutamic-oxaloacetic transaminase 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2806|2806]] * **UniProt**: [[https://www.uniprot.org/uniprot/P00505|P00505]] * **Interactions**: [[https://thebiogrid.org/search.php?search=GOT2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GOT2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/138150|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Catalyzes the irreversible transamination of the L- tryptophan metabolite L-kynurenine to form kynurenic acid (KA). Plays a key role in amino acid metabolism. Important for metabolite exchange between mitochondria and cytosol. Facilitates cellular uptake of long-chain free fatty acids. {ECO:0000269|PubMed:9537447}. |Aminotran 1 2| |glutamate catabolic process to 2-oxoglutarate| |glutamate catabolic process to aspartate| |fumarate metabolic process| |aspartate biosynthetic process| |L-aspartate:2-oxoglutarate aminotransferase activity| |4-hydroxyproline catabolic process| |kynurenine-oxoglutarate transaminase activity| |aspartate catabolic process| |L-kynurenine metabolic process| |oxaloacetate metabolic process| |glutamate catabolic process| |aspartate metabolic process| |glyoxylate metabolic process| |kynurenine metabolic process| |dicarboxylic acid biosynthetic process| |4-hydroxyproline metabolic process| |2-oxoglutarate metabolic process| |amino acid binding| |dicarboxylic acid catabolic process| |aspartate family amino acid catabolic process| |aspartate family amino acid biosynthetic process| |response to muscle activity| |benzene-containing compound metabolic process| |glutamine family amino acid catabolic process| |cellular modified amino acid catabolic process| |glutamate metabolic process| |response to isoquinoline alkaloid| |response to morphine| |T-tubule| |gluconeogenesis| |lactation| |hexose biosynthetic process| |aspartate family amino acid metabolic process| |monosaccharide biosynthetic process| |cellular aldehyde metabolic process| |pyridoxal phosphate binding| |response to activity| |alpha-amino acid biosynthetic process| |glutamine family amino acid metabolic process| |cellular ketone metabolic process| |fatty acid transport| |body fluid secretion| |response to anesthetic| |cellular amino acid biosynthetic process| |dicarboxylic acid metabolic process| |phospholipid binding| |alpha-amino acid catabolic process| |response to alkaloid| |glucose metabolic process| |cellular amino acid catabolic process| |carbohydrate biosynthetic process| |response to ethanol| |mammary gland development| |perikaryon| |monocarboxylic acid transport| |hexose metabolic process| |female pregnancy| |response to ammonium ion| |cellular modified amino acid metabolic process| |monosaccharide metabolic process| |alpha-amino acid metabolic process| |multi-multicellular organism process| |response to insulin| |response to alcohol| |organic acid catabolic process| |carboxylic acid catabolic process| |carboxylic acid transport| |organic acid transport| |lipid transport| |response to xenobiotic stimulus| |carboxylic acid biosynthetic process| |organic acid biosynthetic process| |response to antibiotic| |cellular amino acid metabolic process| |lipid localization| |enzyme binding| |mitochondrial matrix| |response to peptide hormone| |mitochondrial inner membrane| |gland development| |small molecule catabolic process| |cofactor metabolic process| |organic anion transport| |response to peptide| |carbohydrate metabolic process| |regulation of body fluid levels| |response to toxic substance| |monocarboxylic acid metabolic process| |anion transport| |small molecule biosynthetic process| |protein-containing complex| |cell surface| |protein homodimerization activity| |response to hormone| |carboxylic acid metabolic process| |response to organic cyclic compound| |multi-organism reproductive process| |response to organonitrogen compound| |oxoacid metabolic process| |response to drug| |organic acid metabolic process| |organonitrogen compound catabolic process| |response to nitrogen compound| |secretion| |mitochondrion| |ion transport| |RNA binding| |organonitrogen compound biosynthetic process| |reproductive process| |reproduction| |response to endogenous stimulus| |response to oxygen-containing compound| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|-2.38| |[[:results:exp272|CHIR-124 0.04μM R06 exp272]]|-2.2| |[[:results:exp156|UNC2400 2μM R03 exp156]]|-1.93| |[[:results:exp232|Epothilone-D 0.004 to 0.006μM on day4 R05 exp232]]|-1.87| |[[:results:exp464|Calcipotriol 5μM R08 exp464]]|-1.86| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|1.7| |[[:results:exp419|Tunicamycin 0.04 to 0.075μM on day4 R07 exp419]]|1.71| |[[:results:exp507|Monensin 0.3μM R08 exp507]]|1.73| |[[:results:exp13|Chloramphenicol 20μM R00 exp13]]|1.78| |[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|1.8| |[[:results:exp450|Artemisinin 50μM R08 exp450]]|1.81| |[[:results:exp392|PT-1 25μM R07 exp392]]|1.95| |[[:results:exp160|Ribavirin 10 to 15μM on day4 R04 exp160]]|1.96| |[[:results:exp483|FTY720 3μM R08 exp483]]|2.07| |[[:results:exp513|ONC212 0.15μM R08 exp513]]|2.21| |[[:results:exp415|Trichostatin-A 0.06μM R07 exp415]]|2.22| |[[:results:exp189|Temozolomide 200μM R04 exp189]]|2.98| ^Gene^Correlation^ |[[:human genes:m:mdh2|MDH2]]|0.467| |[[:human genes:e:ecsit|ECSIT]]|0.435| |[[:human genes:r:rbfa|RBFA]]|0.424| |[[:human genes:a:abhd11|ABHD11]]|0.421| |[[:human genes:c:c16orf80|C16orf80]]|0.419| |[[:human genes:f:fkbpl|FKBPL]]|0.414| |[[:human genes:m:mcat|MCAT]]|0.408| |[[:human genes:n:ndufa2|NDUFA2]]|0.406| |[[:human genes:m:mto1|MTO1]]|0.405| Global Fraction of Cell Lines Where Essential: 5/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|2/28| |bone|0/25| |breast|0/33| |central nervous system|1/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|1/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|1/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2077 * **Expression level (log2 read counts)**: 7.35 {{:chemogenomics:nalm6 dist.png?nolink |}}